Search Results 1131-1140 of 18472 for Immunode

1. Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients - Mayo Clinic

   History of human immunodeficiency virus with acquired immunodeficiency syndrome at Screening. Active bacterial or fungal infection that is clinically ...

2. A Study to Evaluate Belinostat and Guadecitabine or ASTX727 to Treat Unresectable and Metastatic Conventional Chondrosarcoma - Mayo Clinic

   Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this ...

3. Efficacy, Safety, And Tolerability Study Of Lunsekimig Compared With Placebo In Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized By An Eosinophilic Phenotype PERSEPHONE - Mayo Clinic

   History of human immunodeficiency virus (HIV) infection or positive HIV Type 1 (HIV-1)/HIV Type 2 (HIV-2) serology or positive HIV deoxyribonucleic acid ...

4. Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor - Mayo Clinic

   Known human immunodeficiency virus, active hepatitis B, active hepatitis C, or active mycobacterium tuberculosis infection. If female, the patient is ...

5. A Study of an Implantable System for Remodulin Post Approval - Mayo Clinic

   Inclusion Criteria: Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements ...

6. Efficacy and Safety of Seralutinib in Adult Subjects With PAH - Mayo Clinic

   Human immunodeficiency virus (HIV)-associated PAH, schistosomiasis associated PAH, PAH associated with portal hypertension, or pulmonary veno-occlusive disease ...

7. Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) - Mayo Clinic

   toxicity. 13. Participant has untreated, known human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV). In addition ...

8. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

   Known human immunodeficiency virus infection. Presence of hepatitis B surface antigen (HbsAg) or hepatitis B core antibody (anti-HbcAb), at Screening or ...

9. Macroglobulinemia Clinical Trials - Mayo Clinic Research

   The purpose of this study is to evaluate the safety and effectiveness of the BCL2 inhibitor BGB-11417 in participants with relapsed/refractory Waldenström's ...

10. Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Positive test for hepatitis B, C or HIV (Human Immunodeficiency Virus) virus; Previous treatment with checkpoint inhibitor drugs; Active CNS metastases or ...